Canada markets closed

Marvel Biosciences Corp. (MRVL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.09000.0000 (0.00%)
At close: 01:01PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.58M
Enterprise Value 4.02M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)226.82
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.78

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 3-37.93%
S&P500 52-Week Change 314.91%
52 Week High 30.1450
52 Week Low 30.0100
50-Day Moving Average 30.0719
200-Day Moving Average 30.0838

Share Statistics

Avg Vol (3 month) 337.96k
Avg Vol (10 day) 369.3k
Shares Outstanding 539.79M
Implied Shares Outstanding 639.79M
Float 832.46M
% Held by Insiders 129.85%
% Held by Institutions 10.00%
Shares Short (Nov 29, 2023) 44.94k
Short Ratio (Nov 29, 2023) 40.12
Short % of Float (Nov 29, 2023) 4N/A
Short % of Shares Outstanding (Nov 29, 2023) 40.01%
Shares Short (prior month Oct 30, 2023) 425.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2023
Most Recent Quarter (mrq)Jul 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-172.83%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.19M
Net Income Avi to Common (ttm)-2.29M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)556.62k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.48
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-1.33M
Levered Free Cash Flow (ttm)-432.9k